Children With Inflammatory Bowel Disease in the COVID-19 Main Endemic Focus: The Lombardy Experience

Frontiers in Pediatrics

Costantino De Giacomo¹  Chiara Moretti¹  Marina Di Stefano²  Paola Sgaramella²  Valentina Motta³  Silvia Salvatore⁴  Serena Arrigo⁴  Roberto Panceri⁵  Giovanna Zuin⁵  Elena Pozzi⁶  Dario Dilillo⁶  Rosaria Celano⁷  Federica Nuti⁷  Lorenzo D'Antiga⁸  Lorenzo Norsa⁸  Naire Sansotta⁸ 

[1] Department of Pediatrics ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;Department of Pediatrics, IRCCS San Raffaele Scientific Institute, Milan, Italy;Department of Pediatrics, Ospedale Maggiore, Crema, Italy;Department of Pediatrics, Ospedale “F. Del Ponte”, University of Insubria, Varese, Italy;Department of Pediatrics, University of Milano Bicocca, FMBBM, San Gerardo Hospital, Monza, Italy;Department of Pediatrics, V. Buzzi Children's Hospital, University of Milan, Milan, Italy;Intermediate Pediatric Care Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy;Paediatric Hepatology Gastroenterology and Transplantation, Papa Giovanni XXIII Hospital, Bergamo, Italy;

关键词: inflammatory bowel disease;    children;    COVID-19;    immunosuppression;    SARS-CoV-2;   

DOI  :  10.3389/fped.2021.607285

来源: Frontiers

【 授权许可】

CC BY